Prevention of transmission: Pharmaceutical and obstetrics approaches

Obstetrics and Gynecology Clinics of North America

Volumn 24, Issue 4, 1997, Pages 785-795

  Tuomala, R E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

CHILDBIRTH; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERINATAL INFECTION; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0031463683     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70344-2     Document Type: Article

References (49)

1. E.J. Abrams P.B. Matheson P.A. Thomas Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group Pediatrics 96 1995 451 458
2. R.J. Biggar P.G. Miotti T.E. Taha Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission Lancet 347 1996 1647 1650
3. Blanche S, Mayaux MJ, Mandelbrot L, et al: Acceptability and impact of zidovudine prevention on mother-to-child transmission in France [abstract 380]. In Proceedings from the Fourth Conference on Retroviruses and Opportunistic Infection, Washington, DC, January 22–26, 1997, p 176
4. W. Borkowsky K. Krasinski Y. Cao Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes J Pediatr 125 1994 345 351
5. P.J. Boyer M. Dillon M. Navaie Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission Lancet 347 1996 1647 1650
6. Bryson YJ: Perinatal transmission of HIV: Pathogenesis and therapeutic intervention. In Proceedings of the 3rd National Conference in Retroviruses and Opportunistic Infections, Washington, DC, January 28–February 1, 1996, p 169
7. M. Bulterys J.J. Goedert From biology to sexual behaviour—towards the prevention of mother-to-child transmission of HIV AIDS 10 1996 1287 1288
8. Burchett SK, Kornegay J, Pitt J, et al: Assessment of maternal plasma HIV viral load as a correlate of vertical transmission. In Proceedings of the Third National Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28–February 1, 1996
9. D.N. Burns S. Landesman L.R. Muenz Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels J Acquir Immune Defic Syndr 7 1994 718 726
10. C.C. Carpenter M.A. Fischl S.M. Hammer Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. International AIDS Society–USA JAMA 276 1996 146 154
11. Centers for Disease Control Public Health Service task force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus MMWR 43 RR-11 1994 1 21
12. Centers for Disease Control US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women MMWR 44 RR-7 1995 1 14
13. A.M. Comeau J. Pitt G.V. Hillyer Early detection of human immunodeficiency virus on dried blood spot specimens: Sensitivity across serial specimens. Women and Infants Transmission Study Group J Pediatr 129 1996 111 118
14. E.M. Connor R.S. Sperling R. Gelber Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group N Engl J Med 331 1994 1173 1180
15. E.R. Cooper R.P. Nugent C. Diaz After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group J Infect Dis 174 1996 1207 1211
16. Delta Coordinating Committee Delta: A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals Lancet 348 1996 283 291
17. R. Dickover E.M. Garratty S.A. Herman Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load JAMA 275 1996 599 605
18. A.M. Duliege C.I. Amos S. Felton Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins: International Registry of HIV-Exposed Twins J Pediatr 126 1995 625 632
19. D.T. Dunn C.D. Brandt A. Krivine The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intrauterine and intrapartum transmission AIDS 9 1995 F7 11
20. D.T. Dunn M.L. Newell C. Mayaux Mode of delivery and vertical transmission of HIV-1: A review of prospective studies J Acquir Immune Defic Syndr 7 1994 1064 1066
21. J.L. Ecker The cost-effectiveness of human immunodeficiency virus screening in pregnancy Am J Obstet Gynecol 174 1996 716 721
22. Eastman PS, Shapiro DE, Coombs RW, et al: Maternal genotypic ZDV resistance and failure of ZDV therapy to prevent mother-child HIV-1 transmission. In Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22–26, 1997, p 160
23. G. Fang H. Burger R. Grimson Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission Proc Natl Acad Sci USA 92 1995 12100 12104
24. S.A. Fiscus A.A. Adimora V.J. Schoenbach Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties JAMA 275 1996 1483 1488
25. R.D. Gorsky P.G. Farnham W.L. Straus Preventing perinatal transmission of HIV—costs and effectiveness of a recommended intervention Public Health Rep 111 1996 335 341
26. S.M. Hammer D.A. Katzenstein M.D. Hughes A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter N Engl J Med 335 1996 1081 1090
27. Koup RA, Cao Y, Ho DD, et al: Lack of a maternal viral threshold for vertical transmission of HIV-1. In Proceedings of the Third National Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28–February 1, 1996, p 161
28. S.H. Landesman L.A. Kalish D.N. Burns Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child: The Women and Infants Transmission Study N Engl J Med 334 1996 1617 1623
29. E.J. Landsberger K. McGuinness S.D. Biggers The impact of zidovudine on the reduction of perinatal transmission in NYC parturients Int Conf AIDS 11 1996 368
30. R. Lewis J.M. O'Brien D.T. Ray The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population Am J Obstet Gynecol 173 1995 1329 1333
31. L. Mandelbrot M.J. Mayaux A. Bongain Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group Am J Obstet Gynecol 175 1996 661 667
32. P.B. Matheson E.J. Abrams P.A. Thomas Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1: The New York City Perinatal HIV Transmission Collaborative Study Group J Infect Dis 172 1995 353 358
33. Mauskopf JA, Paul JE, Wichman DS, et al: Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine: Implications for HIV screening. JAMA 276:132–138
34. M.J. Mayaux E. Dussaix J. Isopet Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohort studies. SEROGEST Cohort Group J Infect Dis 175 1997 172 175
35. Mofenson LM: Mother-child HIV-1 transmission: Timing and determinants. Obstet Gynecol Clin North Am, in press
36. P. Nair L. Alger S. Hines Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women J Acquir Immune Defic Syndr 6 1993 298 302
37. M.L. Newell D. Dunn C.S. Peckham Caesarean section and risk of vertical transmission of HIV-1 infection: European Collaborative Study Lancet 343 1994 1464 1467
38. M.J. O'Sullivan P.J. Boyer G.B. Scott The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group Am J Obstet Gynecol 168 1993 1510 1516
39. Panel on Clinical Practices for Treatment of HIV Infection: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Washington, DC, US Public Health Service, in press
40. E.M. Rodriguez L.M. Mofenson B.H. Chang Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission AIDS 10 1996 273 282
41. L.D. Saravolatz D.L. Winslow G. Collins Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter N Engl J Med 335 1996 1099 1106
42. R.S. Sperling D.E. Shapiro R.W. Coombs Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group N Engl J Med 335 1996 1621 1629
43. M.E. St. Louis M. Kamenga C. Brown Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors JAMA 269 1993 2853 2859
44. M. Temmerman A.O. Nyong'o J. Bwayo Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection Am J Obstet Gynecol 172 1995 700 705
45. P.A. Thomas J. Weedon K. Krasinski Maternal predictors of perinatal human immunodeficiency virus transmission: The New York City Perinatal HIV Transmission Collaborative Study Group Pediatr Infect Dis J 13 1994 489 495
46. P.A. Tovo M. de Martino C. Gabiano Mode of delivery and gestational age influence on perinatal HIV-1 transmission: Italian Register for HIV Infection in Children J Acquir Immune Defic Syndr 11 1996 88 94
47. P. Villari C. Spino T.C. Chalmers Cesarean section to reduce perinatal transmission of human immunodeficiency virus Online Journal of Current Clinical Trials July 8, 1993 document 74.
48. Weiser B, Burger H, Weislow O, et al: AZT resistance and HIV-1 mother-to-child transmission. In Proceedings of the 3rd National Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28–February 1, 1996, p 77
49. A.A. Wiznia M. Crane G. Lambert Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center JAMA 275 1996 1504 1506